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Abstract
Background—The usefulness of a low butyrylcholinesterase activity on admission for
predicting severity in acute organophosphorus insecticide poisoning has long been debated.
Previous studies have been confounded by the inclusion of multiple insecticides with differing
inhibitory kinetics.
Aim—We aimed to assess the usefulness of admission butyrylcholinesterase activity, together
with plasma organophosphorus concentration, for predicting death with identified
organophosphorus insecticides.
Design—A prospective cohort of self-poisoned patients
Methods—We prospectively studied 91 and 208 patients with proven dimethoate or chlorpyrifos
self-poisoning treated using a standard protocol. Plasma butyrylcholinesterase activity and
organophosphorus concentration were measured on admission and clinical outcomes recorded.
Results—The usefulness of a plasma butyrylcholinesterase activity <600mU/ml on admission
varied markedly - while highly sensitive in chlorpyrifos poisoning (sensitivity 11/11 deaths;
100%, 95%CI 71.5-100), its specificity was only 17.7% (95%CI 12.6-23.7). In contrast, while
poorly sensitive for deaths in dimethoate poisoning (12/25 patients; 48%, 95%CI 27.9-68.7) it was
reasonably specific (86.4%, 95%CI 75.7-93.6). A high organophosphorus concentration on
admission was associated with worse outcome; however, a clear threshold concentration was only
present for dimethoate poisoning.
Conclusions—Plasma butyrylcholinesterase activity on admission can provide useful
information; however, it must be interpreted carefully. It can only be used to predict need for
critical care and death when the insecticide ingested is known and its sensitivity and specificity for
that insecticide has been studied. Plasma concentration of some organophosphorus insecticides
Correspondence: M Eddleston, SPIB, Royal Infirmary, 51 Little France Crescent, Edinburgh EH16 4SA, UK. t +44-131-242-1383.
eddlestonm@yahoo.com. .
Europe PMC Funders Group
Author Manuscript
QJM. Author manuscript; available in PMC 2009 January 12.
Published in final edited form as:
QJM. 2008 June ; 101(6): 467–474. doi:10.1093/qjmed/hcn026.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
predicts outcome. The development of rapid bedside tests for organophosphorus detection may aid
early assessment of severity.
Introduction
Organophosphorus (OP) insecticide self-poisoning is a major global health problem, 1,2
with hundreds of thousands of deaths each year.3,4 Identifying patients with a poor
prognosis who will benefit from intensive care support is currently difficult.5
OPs inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes. 5
AChE inhibition causes clinical features due to overstimulation of cholinergic synapses in
the parasympathetic system, neuromuscular junction, and central nervous system.6 BuChE
inhibition, by contrast, appears not to result in clinical features.5 However, BuChE activity
is more easily measured than AChE activity and BuChE assays are widely available and
therefore commonly recommended in the early assessment of OP pesticide poisoned
patients. In 1971, Namba and colleagues proposed a severity scoring system that included
the measurement of BuChE:7 mild poisoning had BuChE 20-50% of normal activity,
moderate poisoning 10-20%, and severe poisoning <10%.
The usefulness of this approach has been much debated. Despite studies showing BuChE to
be a poor predictor of outcome and response to therapy,8-10 some clinicians continue to use
it in the early assessment of OP pesticide severity.11-19 The clinical studies that have been
done to assess its usefulness, however, have been confounded by the presence of multiple
OP pesticides.14,20-26
It is possible that BuChE activity may be useful for particular OPs, if they can be
confidently identified on admission. The aim of this study was therefore to determine the
usefulness of admission plasma BuChE activity or OP concentration for predicting need for
critical care or death, using patients proven to have ingested dimethoate or chlorpyrifos -
two OP pesticides that are common problems across rural Asia.
Methods
Patients
Patients were seen on admission to three Sri Lankan hospitals as part of an RCT of acute
self-poisoning that started 31 Mar 2002 in Anuradhapura, 4 Jun 2002 in Polonnaruwa, and
23 Nov 2002 in Kurunegala. Patients for this study were seen until 19 Feb 2003 in
Kurunegala and 31 Dec 2003 in Anuradhapura and Polonnaruwa. Ethics approval was
obtained from the Oxfordshire Clinical Research Ethics Committee and Faculty of Medicine
Ethics Committee, Colombo.
The management of these patients was uniform on the two hospitals and has been previously
described.27,28 Briefly, patients were resuscitated on arrival with fluids and atropine, and
administered pralidoxime chloride 1g q6h for 1-3 days. Patients remained under the care of
the responsible consultant physician and were treated using protocols agreed between ward
doctors and study team.27 All decisions were made on the basis of the patient’s clinical
condition and not the particular OP ingested.
Once resuscitated, patients or their relatives were approached concerning recruitment to a
RCT of activated charcoal (ISRCTN02920054) that was nested into the cohort; informed
signed consent was obtained from patients or relatives. The RCT was stopped in October
2004 after the planned final interim analysis showed no effect of activated charcoal on
death.29
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Consecutive patients recruited to the study were included in this study if they had a history
of chlorpyrifos or dimethoate ingestion (as indicated by patient or relatives, transferring
doctor, or pesticide bottle) and either OP was subsequently detected in a plasma sample
taken on admission. Patients who ingested more than one OP or other poisons in addition to
the OP (except for alcohol) were excluded from the study.
Toxicological analysis
Blood samples were taken on admission from patients recruited to the RCT until December
2003. Samples were placed at 4C immediately after phlebotomy, plasma extracted after
centrifugation within 10 minutes, and the samples placed at -23C.
Plasma from 376 patients (240 chlorpyrifos, 136 dimethoate) were then assayed for BuChE
activity and OP concentration. All analyses were done in Munich. BuChE activity was
assessed as described.30,31 BuChE activity in unexposed people is known to vary widely.32
In plasma samples collected in an identical fashion from patients in the RCT with Thevetia
peruviana poisoning (n=72), but no known exposure to OP or carbamate pesticides, we
found a median value of 4500 mU/mL (3200 to 5200 IQR, Eyer, unpublished observations).
Given the likelihood of unperceived exposure we conservatively took 600 mU/mL as 10%
of normal activity. OPs in plasma were quantified by reversed phase HPLC and UV
detection. The lower limits of quantitation were 0.1 and 1.0 nmol/ml plasma for chlorpyrifos
and dimethoate, respectively.28
Statistics
The primary data analysis was performed in GraphPad Prism (version 4). Clinical
characteristics were summarised using counts (percentages) for categorical variables and the
median (interquartile range [IQR]) for non-normally distributed continuous variables.
Logistic regression to examine for confounding effects of time from ingestion for blood
sampling was performed using Stata v10.
Results
Between 31 Mar 2002 and 31 Dec 2003, admission blood samples for 376 patients with a
history of dimethoate or chlorpyrifos self-poisoning were analysed for BuChE activity and
OP concentration. The relevant OP could not be detected in 77 patients; these patients are
not further discussed.
208 patients had ingested chlorpyrifos (median OP concentration 1.24 uM [inter-quartile
range (IQR) 0.38 to 3.14]; median BuChE activity 34 mU/mL [IQR 0 to 300]) and 91 had
ingested dimethoate (median OP concentration 342 uM [IQR 159 to 643]; median BuChE
activity 1277 mU/mL [IQR 678 to 2349]). Both median BuChE activity and median OP
concentration were significantly different between OPs (P<0.0001 Mann Whitney test).
Twenty five of 91 (27.5%, 95%CI 18.6 to 37.8) dimethoate poisoned patients died compared
to 11/208 (5.3%, 95%CI 2.7 to 9.3) with chlorpyrifos poisoning. Patients who died from
both pesticides were older and more likely to be male; however, there was no difference in
time to admission between fatal and non-fatal cases (table 1). Blood OP concentrations were
greater in patients who died compared to those who survived for both OPs (figure 1, table 1,
both P<0.0001).
BuChE activity on admission
The usefulness of plasma BuChE activity on admission differed between OPs (figure 2). A
value less than 600 mU/ml (10% of normal activity in our laboratory) was highly sensitive
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for death in chlorpyrifos patients (sensitivity 11/11; 100%, 95%CI 71.5 to 100) but not
specific, since 163/198 survivors also had values <600 mU/ml (specificity 17.7%, 12.6 to
23.7). In contrast, a value of <600 had low sensitivity to predict deaths from dimethoate
poisoning (12 deaths out of 25 patients; 48%, 27.9 to 68.7) but was reasonably specific
(86.4%, 75.7 to 93.6) since only 9 of 66 survivors had a value <600 mU/ml on admission.
We constructed plots of BuChE activity (figure 3) against time since ingestion for both
dimethoate and chlorpyrifos to assess whether time since ingestion was a factor affecting its
usefulness on admission. Visual inspection and logistic regression analysis indicated that
incorporating time post ingestion did not improve prediction of outcome using BuChE
activity (dimethoate: pseudo r2 = 0.21, 0.17; chlorpyrifos: pseudo r2 = 0.11, 0.05; with and
without time as a factor, respectively).
We performed ROC analysis of the specificity and sensitivity of BuChE activity on analysis
in predicting a lethal outcome (figure 4). BuChE activity performed poorly with an AUC of
0.77 (95%CI 0.66 to 0.87) for dimethoate and 0.60 (04.5 to 0.75) for chlorpyrifos. There
were very different optimal cut-off points (according to Youden’s index) for the two OPs:
chlorpyrifos <250 mU/ml (or 4% of normal) vs dimethoate <875 mU/ml (or 15% of
normal).
OP concentration on admission
We also assessed the usefulness of OP concentration on admission for predicting death. We
used Youden’s index to identify cut-points with the highest combined value of sensitivity
and specificity. For dimethoate a concentration cut-off of >475 μM gave a sensitivity of
96% (95%CI: 80 to 100%) and a specificity of 85% (74 to 92%) and a positive likelihood
ratio of 6.3. For chlorpyrifos concentration, the optimal cut-off was >3.0 μM which gave a
sensitivity of 100% (95%CI: 72 to 100%) and a specificity of 77% (70 to 82%) and a
positive likelihood ratio of 4.3.
We constructed plots of OP concentration (figure 5) against time since ingestion for both
dimethoate and chlorpyrifos to assess whether time since ingestion was a factor affecting the
usefulness of either value on admission. Visual inspection and logistic regression analysis
indicated that incorporating time post ingestion did not improve prediction of outcome
(dimethoate: r2 = 0.637, 0.637; chlorpyrifos: r2 = 0.16 and 0.13; with and without time as a
factor, respectively).
ROC analysis of the specificity and sensitivity of OP concentration on analysis in predicting
a lethal outcome showed a different picture for the two OPs (figure 4). The dimethoate
concentration was both highly sensitive and specific with an AUC of 0.96 (95%CI: 0.92 to
1.00). The AUC for chlorpyrifos concentration ROC was also good at 0.88 (95%CI 0.82 to
0.93), but as can be seen from figure 5 it lacked high specificity at any value where there
was acceptable sensitivity.
We also postulated there might be a relationship between higher OP concentration on
admission and a shorter time to death in fatal cases; however, this was not apparent on
review of the data (figure 6).
Discussion
Since Namba’s review of OP pesticide poisoning in 1971,7 a BuChE measurement on
admission has been used by some clinicians to stratify severity - values <10% of normal
indicating a severe poisoning. However, we did not find this cut-off to be helpful since
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different OPs inhibit BuChE to differing degrees compared to their inhibition of the
clinically important AChE. BuChE activity therefore does not always reflect severity.
For example, the active metabolite of chlorpyrifos (chlorpyrifos-oxon) is >500-times more
potent an inhibitor of BuChE than AChE;33 in consequence, all patients with sufficient
AChE inhibition to produce clinical symptoms will have markedly depressed BuChE
activity.28 In contrast, the dimethoate active metabolite (omethoate) inhibits cholinesterases
more slowly,28,34 and BuChE activity can be near normal in symptomatic patients.28
Overall, a BuChE activity on admission is only useful when the OP pesticide has been
identified and when its sensitivity and specificity is known for that particular OP.
BuChE activity must be interpreted carefully. Many patients with mild to moderate
chlorpyrifos poisoning had severely inhibited BuChE on admission; by contrast, BuChE was
not severely inhibited in 52% of patients with dimethoate poisoning who died. Nevertheless,
plasma BuChE activity on admission was useful for some patients: in chlorpyrifos
poisoning, an activity >600mU/ml accurately predicted good outcome, while an activity
<600mU/ml predicted death in dimethoate poisoning. However, it was not useful for most
patients - even when the OP was known and the best cut-off values chosen for each OP, the
BuChE performed at a level unacceptable for a clinically useful prognostic test (figure 5).35
We found the OP concentration on admission to be potentially useful, particularly for
dimethoate poisoned patients. All patients presenting with a dimethoate concentration of
>750 uM died; two-thirds of fatal cases had a dimethoate concentration greater than this
value on admission. In contrast, in chlorpyrifos poisoning, an OP concentration of >3 uM
was sensitive for a poor outcome but this value had a poor specificity of ∼77%. Since the
case fatality of chlorpyrifos poisoning is 6-7%, more than 80% of people with a
concentration >3 uM on admission survive.
The reasons for this difference in the utility of concentration data are likely to be complex.
AChE inhibition occurs more quickly in chlorpyrifos poisoning than in dimethoate
poisoning, with patients becoming ill more quickly and requiring urgent therapy within just
a few hours.28 Patients die from moderate poisoning if they do not reach hospital in time or
get rapid resuscitation on arrival. Many chlorpyrifos deaths appear to be due to late
respiratory complications, such as pneumonia or acute respiratory distress syndrome, not
closely correlated with initial poisoning severity, that result from pre-hospital onset of
poisoning and subsequent complications.
In contrast, severe dimethoate poisoning has a sub-acute presentation and most deaths occur
from a cardiovascular cause after 12 hours that is not apparently modifiable by any
treatment.28 In consequence, moderately poisoned dimethoate patients reach hospital alive
and receive treatment in time, whereas severely poisoned patients die despite treatment.
Unexpectedly, despite the very strong correlation between dimethoate concentration and
death, within these fatal cases we did not observe a strong relationship between higher OP
concentration on admission and a shorter time to death. The variable time from ingestion to
admission may be obscuring any relationship. Most of these samples were taken from 1-6
hrs - ie potentially during the absorption and disposition phases. It is not therefore possible
to simply adjust for the time to sampling as concentrations may be both rising and falling
during this time. A full exploration of this would require a much better understanding of the
kinetics of dimethoate in overdose to adjust for the time of sampling with PKPD modelling.
In this study, a plasma dimethoate concentration of >750 μm was uniformly fatal, whatever
the time between ingestion and blood sampling. If future research confirms this finding in
more patients and in Western ICUs, this concentration fulfils an ‘All or None’ level of
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evidence for prognosis (level 1c, Oxford Centre for Evidence Based Medicine), i.e no
patients with plasma concentration >750 μm survive. As a result, the effectiveness of
interventions could be assessed outside of a randomised controlled trial.
In conclusion, plasma BuChE activity on admission can provide useful information but it
must be interpreted critically when the particular OP is known. The development of rapid
bedside tests for organophosphorus insecticide detection will greatly aid early assessment of
severity.
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Figure 1.
Median and range of plasma blood concentration on admission for patients poisoned by A)
dimethoate and B) chlorpyrifos.
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Figure 2.
Plasma BuChE activity on admission for individual patients poisoned by A) dimethoate and
B) chlorpyrifos. The lines mark BuChE at 50% and 10% of estimated normal activity (6000
mU/ml).
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Figure 3.
Plot of BuChE activity on admission versus time since ingestion for patients poisoned by A)
dimethoate and B) chlorpyrifos.
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Figure 4.
ROC analysis of BuChE activity (A,B) or OP concentration (C,D) on admission versus time
since ingestion for patients poisoned by dimethoate (A,C) and chlorpyrifos (B,D).
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Figure 5.
Plot of OP concentration on admission versus time since ingestion for patients poisoned by
A) dimethoate and B) chlorpyrifos.
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Figure 6.
Plot of OP concentration on admission versus time interval from ingestion to death for
patients fatally poisoned by A) dimethoate and B) chlorpyrifos.
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